6681 — BrainAurora Medical Technology Cashflow Statement
0.000.00%
Last trade - 00:00- HK$7.47bn
- HK$7.52bn
- CNY122.31m
Annual cashflow statement for BrainAurora Medical Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | |
| Standards: | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | -698 | -502 | -359 | — |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 648 | 398 | 227 | — |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -1.2 | -8.8 | -25.7 | — |
| Change in Accounts Receivable | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -49.2 | -101 | -137 | — |
| Capital Expenditures | -11.1 | -19.1 | -18.1 | — |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -10.4 | -315 | 121 | — |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -21.5 | -334 | 103 | — |
| Financing Cash Flow Items | 109 | 139 | 50.2 | — |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 394 | 140 | 63.5 | — |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 323 | -295 | 29.3 | — |